Medication info

Ogmento Neo Syrup

Prescription medicationSyrupOralExpired
Ingredient · strength
Amoxicillin Hydrate›54.55g / 100gDilute Potassium Clavulanate›3.9g / 100g
Manufacturer / importer
The You Pharmaceutical Co., Ltd.
Appearance
A syrup preparation that is a white to light yellowish powder with a peculiar smell, which dissolves when used.
Packaging
50 milliliters/bottle
Approval status
Expired

MFDS item code 201905338 · Notified 2019.07.29

This product's status changed to Expired on 2024.07.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with hepatic impairment, and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the beginning of a meal. Administration of this medicine at the beginning of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients aged 3 months and older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day, divided into doses given every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
The You Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children

  • Recurrent acute otitis media
  • persistent acute otitis media
  • recurrent acute sinusitis
View approved original text

This medication effectively acts on major respiratory tract bacterial infections such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is particularly used for the treatment of recurrent or persistent acute otitis media and acute sinusitis in pediatric patients. However, this medication is recommended for children with specific risk factors such as having received antibiotic treatment in the past 3 months, being under 2 years old, or attending daycare. Therefore, it is very suitable for treating otitis media and sinusitis in children with these risk factors. This medication plays an important role in alleviating infection symptoms in children and aiding in their rapid recovery. It is used to protect the health of children through safe and effective treatment.

How to take

Adult dose

○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with hepatic impairment, and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the beginning of a meal. Administration of this medicine at the beginning of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients aged 3 months and older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day, divided into doses given every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.

Precautions

This medication contains the artificial sweetener aspartame, which should not be used by patients with phenylketonuria, a genetic disease. Care should be taken not to exceed the acceptable daily limit of aspartame, and a maximum dose is set for adults. Patients who have had hypersensitivity to this medication or to beta-lactam antibiotics may be at risk if they take this medication. In particular, patients with infectious mononucleosis or lymphocytic leukemia are at a higher risk of side effects such as rash and should not be administered this medication. Patients with a history of liver dysfunction or jaundice may experience worsening symptoms when taking this medication, so caution is necessary. This medication contains lactose, so patients with genetic conditions such as galactose intolerance or lactose deficiency should not take it. Patients with impaired liver or kidney function should be cautious when being administered this medication, and dosing intervals may need to be adjusted. Patients with allergies or those who frequently experience bronchial asthma, rash, hives, etc., should be cautious as there is a possibility of side effects when taking this medication. Patients with gastrointestinal symptoms such as vomiting or diarrhea may not absorb the medication properly, so they should consult a physician before taking it. This medication generally has good tolerability, but side effects such as diarrhea, vomiting, skin rash, contact dermatitis, etc., may occur, and in severe cases, administration should be discontinued. If there is pain in the gastrointestinal tract, frequent diarrhea, or bloody stools during administration, the medication should be stopped immediately, and healthcare personnel should be notified. Symptoms of liver dysfunction can occur particularly in elderly patients or those receiving long-term treatment, so regular liver function tests are necessary. Allergic reactions such as itching, rash, severe dermatitis, and anaphylactic shock can occur rarely, so administration should be discontinued immediately if symptoms arise. Blood-related side effects such as leukopenia, thrombocytopenia, and anemia have been reported rarely, and caution is necessary. Central nervous system disorders such as dizziness, headache, and seizures may occur rarely, so if abnormal symptoms develop, consultation with healthcare personnel is required. This medication may interact with other medications, so if other drugs are being taken, it is essential to inform healthcare personnel. Pregnant or breastfeeding women should consult a doctor before taking this medication, and particularly avoid taking it during the first three months of pregnancy. It should not be used in infants under 3 months due to insufficient evidence of safety and effectiveness. When taking the medication, adhere to the prescribed dosage and duration, and do not arbitrarily extend or shorten the duration of use. If any adverse reactions occur after taking the medication, immediately consult a physician to determine whether to discontinue the medication.

Side effects

Contact dermatitis, diaper rash, diarrhea, vomiting, moniliasis, rash, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, anorexia, abdominal pain, abdominal bloating, constipation, colonic pain, acid reflux, melena, xerostomia, acute pancreatitis, candidiasis, antibiotic-associated colitis, hematochezia, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness-like syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, burning, increased secretions, anxiety, restlessness, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, convulsions, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, tooth discoloration, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, interstitial nephritis, diabetic nephropathy, epileptic seizures, hypersensitivity shock, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is best to keep it in a dry place between 1 and 25 degrees Celsius. Storing it this way will help maintain its effectiveness for a long time.

Appearance and packaging

Appearance

A syrup preparation that is a white to light yellowish powder with a peculiar smell, which dissolves when used.

Package unit

50 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.